Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active principle stabilized by at least one maleic anhydride copolymer
A technology of maleic anhydride, active ingredients, applied in drug combination, skin diseases, emulsion delivery, etc., can solve problems such as lack of freshness
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0086] Example 1: Accelerated storage test
[0087] The purpose of this test is to investigate the decomposition of oxidation-sensitive hydrophilic active ingredients after storage at 45°C for 2 months. Various solutions were prepared and their compositions are shown in the table below:
[0088] combination
[0089] The whole solution was adjusted to pH 6 with 8.9 mol / l KOH.
[0090] The percentages of polymer are based on active matter.
[0091] Polymer 1 : Styrene / maleic anhydride (50 / 50) copolymer in the form of 30% ammonium salt in water, by Atofina under the reference name SMA1000H for sale.
[0092] Polymer 2 : Styrene / maleic anhydride (50 / 50) copolymer, in the form of the sodium salt, manufactured by Atofina under the reference name SMA1000HNa for sale.
[0093] The degree of decomposition determined is expressed in the following scale:
[0094] (C 0 -C 2个月 ) / C 0
[0095] and there is C of ascorbic acid at t=0 0 Concentrati...
Embodiment 2
[0105] Example 2: The addition of the combination form of the present invention has an effect on the synthesis of tenascin and collagen VII. Observations of the resulting effects
[0106] This example describes the immunohistochemical labeling of proteins with tenascin and collagen VII by microscopic observation of skin sections, the effect of the addition of a combination of the invention (comprising ascorbic acid and a copolymer of the invention) on reconstituted skin.
[0107] 1. Preparation of Reconstituted Skin
[0108] The reconstituted skin used was prepared according to the protocol described by Asselineau et al. (Models in Dermato. Published by Loire and Maibach, 1987, Vol III, 1-7). Improvements to this scheme are described below:
[0109] -Normal adult skin fibroblasts per equivalent dermis 10 6 The proportion of cells used;
[0110] - The inoculation of keratinocytes is carried out at a ratio of 50 000 cells per ring with a diameter of 1.5 cm. The keratin...
Embodiment 3
[0123] Example 3: O / W Anti-Aging Cream
[0124] The following compositions were prepared in a manner conventional to those skilled in the art.
[0125] Phase A
[0126] Water 18.33g
[0127] Glycerin 3g
[0128] Phase B
[0129] Sorbitan Tristearate 0.68g
[0130] PEG-40 Stearate 1.5g
[0131] Cetyl Alcohol 3g
[0132] Glyceryl Stearate 2.25g
[0133] Myristyl myristate 1.5g
[0134] Ethylhexyl Palmitate 1.5g
[0135] Hydrogenated polyisobutylene 2.5g
[0136] Shorea robusta seed butter 1.5g
[0137] Shea (butyrospermum parkii) (shea butter) fruit 0.5g
[0138] Cyclopentasiloxane 7.5g
[0139] Phenoxyethanol 1g
[0140] Phase C
[0141] Water 43.94g
[0142] Ascorbic acid 5g
[0143] Potassium hydroxide (50% solution) 3g
[0144] Styrene / maleic anhydride copolymer, 30% ammonium salt in water 3.3g
[0145] (SMA1000H , Atofina)
[0146] A thick and soft cream is obtained that combats the signs of aging, in which ascorbic acid has good stability over time. ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com